|1|Independent growth of diffuse large B cell lymphoma and angioimmunoblastic T cell lymphoma originating from composite lymphoma. (24488225)
Tabata R.... Kojima M.
|2|Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome. (23859481)
Fiskvik I.... Holte H.
|3|Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP. (24220563)
Huang X.... Fu K.
|4|Paradoxical Regulation of Hypoxia Inducible Factor-1I+ (HIF-1I+) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma. (24312289)
Bhalla S.... Gordon L.I.
|5|An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and I9SUVmax. (23649463)
Itti E.... Haioun C.
|6|Two Cases of Diffuse Large B-Cell Lymphomas in the Cervical Lymph Nodes in Patients with Low-Grade Gastric Marginal Zone B-Cell Lymphoma (MALT Lymphoma). (23767042)
Jung J.H.... Kim J.H.
|7|Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas. (24223701)
Rosolowski M.... Loeffler M.
|8|Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma. (24054064)
Lin S.... Wenwen R.
|9|Combination of YM155, a survivin suppressant with a STAT3 inhibitor: a new strategy to treat diffuse large B-cell lymphoma. (23746965)
Kaneko N.... Mori M.
|10|The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. (24357794)
Troppan K.... Pichler M.
|11|Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. (23807169)
Cheah C.Y.... Seymour J.F.
|12|Case report and review of primary bone diffuse large B-cell lymphoma involving the calcaneus. (23628193)
Blume P.... Mohammed S.
|13|Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy. (23560495)
Pasanen A.K.... Kuittinen O.
|14|Composite lymphoma after chemotherapy with regressed diffuse large B-cell lymphoma and transformed cytotoxic T-cell lymphoma. (23009219)
Dy J.A.... Chuang S.S.
|15|Lenalidomide in diffuse large B-cell lymphomas. (22792112)
Chiappella A.... Vitolo U.
|16|Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma]. (22932402)
Yao X.X.... Gao N.
|17|Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy. (21067447)
Yi J.H.... Kim W.S.
|18|Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. (21173233)
Kloo B.... Krappmann D.
|19|Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas. (21638516)
Guney S.... Bastard C.
|20|Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency. (21094993)
Newell A.... Roifman C.M.
|21|Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas. (21832150)
Al-Humood S.A.... Al-Mulla F.
|22|Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. (20651244)
Nie K.... Tam W.
|23|A rare reason of foot drop caused by primary diffuse large b-cell lymphoma of the sciatic nerve: case report. (19415174)
Kahraman S.... Sirin S.
|24|A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. (20395518)
Schniederjan S.D.... Mann K.P.
|25|Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases. (19935644)
Hattab E.M.... Al-Abbadi M.A.
|26|Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era. (20919853)
Provencio M.... Bellas C.
|27|Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP. (19629486)
Chae Y.S.... Lee M.H.
|28|Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation. (20800019)
Song Y.... Zhang X.
|29|Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. (20200556)
Singh R.R.... Vega F.
|30|Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome. (19500133)
Xu W.... Shen H.
|31|BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution. (19508293)
Thunberg U.... Berglund M.
|32|Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma. (19373655)
Saez A.I.... Piris M.A.
|33|Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells. (17916749)
Cillessen S.A.... Oudejans J.J.
|34|Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. (18539616)
Amara K.... Korbi S.
|35|Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas. (18312353)
van Galen J.C.... Oudejans J.J.
|36|Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience. (18925695)
KoraA8 P.... Dominis M.
|37|Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin. (17516749)
Kim S.H.... Yang W.I.
|38|ERCC1 Expression in Diffuse Large B-Cell Lymphoma Patients Treated with a Cisplatin-Based Regimen : A Brief Communication. (19190690)
Azim H.A.... Peccatori F.A.
|39|Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses. (18006767)
Chang K.C.... Lin Y.H.
|40|Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. (16424392)
Tam W.... Knowles D.M.
|41|CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-). (16923582)
Yokose N.... Dan K.
|42|Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases]. (17134546)
Wang W.Y.... Liao D.Y.
|43|Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. (14979479)
Ueda C.... Ohno H.
|44|A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein. (15162151)
Liggins A.P.... Banham A.H.
|45|Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetylglucosaminyltransferase V in human diffuse large B cell lymphoma. (14534692)
Suzuki O.... Abe M.
|46|T(11;18)(q21;q21) in gastric MALT lymphoma and diffuse large B-cell lymphoma of Chinese patients. (14502259)
Huang X.... Du M.Q.
|47|Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome]. (11868363)
Yanagiya N.... Miura I.
|48|Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. (12407182)
Wang X.... Ye B.H.
|49|A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. (10931213)
Skacel M.... Hsi E.D.
|50|De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. (7541611)
Matolcsy A.... Knowles D.M.